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Effect of fetal and child health on kidney development and 
long-term risk of hypertension and kidney disease
Valerie A Luyckx, John F Bertram, Barry M Brenner, Caroline Fall, Wendy E Hoy, Susan E Ozanne, Bjorn E Vikse
Developmental programming of non-communicable diseases is now an established paradigm. With respect to 
hypertension and chronic kidney disease, adverse events experienced in utero can affect development of the fetal 
kidney and reduce final nephron number. Low birthweight and prematurity are the most consistent clinical surrogates 
for a low nephron number and are associated with increased risk of hypertension, proteinuria, and kidney disease in 
later life. Rapid weight gain in childhood or adolescence further compounds these risks. Low birthweight, prematurity, 
and rapid childhood weight gain should alert clinicians to an individual’s lifelong risk of hypertension and kidney 
disease, prompting education to minimise additional risk factors and ensuring follow-up. Birthweight and prematurity 
are affected substantially by maternal nutrition and health during pregnancy. The best maternal health and early 
childhood nutrition could, therefore, attenuate this programming cycle and reduce the global burden of hypertension 
and kidney disease in the future. 
Introduction 
[A: We have edited your paper to avoid repetition, enhance 
readability, reduce length, and achieve con sistency with 
Lancet style] Hypertension is now the leading risk factor 
for the global disease burden, and it is a major cause and 
result of chronic kidney disease.1 Global deaths from 
kidney disease have risen by 83% since 1990.2 Recognition 
of the burden of chronic kidney disease, its risk factors, 
and implementation of prevention strategies is, therefore, 
key to saving many lives. 
Increasingly, the important contribution of fetal and early 
childhood development to growth in non-com municable 
disease is being recognised.3,4 Epi demiological observation 
suggests a graded risk for hypertension, type 2 diabetes, 
cardiovascular disease, and chronic kidney disease across 
the range of fetal and early childhood development.3,4 
Acknowledgment of this paradigm is important because 
interventions to optimise fetal and child health as 
strategies to prevent adult non-communicable diseases 
have great potential economic, societal, and individual 
benefit.4 Many developing countries carry the dual burdens 
of undernutrition and overnutrition, contributing to the 
vicious cycles of poor maternal health, suboptimum fetal 
[A: We have edited your paper to avoid repetition, enhance readability, reduce 
length, and achieve consistency with Lancet style. Please check that all drug names 
are the rINNs (recommended international non-proprietary names) where 
possible, and please ensure that the dose, route, and frequency of administration 
are correct. Please note that we try to keep use of abbreviations to a minimum so I 
have spelt out where necessary]
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Key messages 
Ǧ 
hypertension, proteinuria, and chronic kidney disease in 
later life
Ǧ ƽȜȠʏ
Ȥǧȡʏƽƽ
proportion of the world’s children are at risk of hypertension 
and kidney disease
Ǧ 
congenital reduction in nephron number; in turn, small 
numbers of nephrons are associated with raised blood 
pressure and increased susceptibility to kidney disease [A: 
merged these two points, we prefer to list 5 key points]
Ǧ ƽ
maternal diabetes in utero, is associated with increased risk 
of proteinuria and kidney disease in later life
Ǧ ʲ
maternal nutrition and health before and during pregnancy 
and by the mother’s own birthweight, indicating the 
ʲ
Ǧ ǂǂ
in childhood or adolescence is associated with increased risk 
of high blood pressure, progression of renal disease, type 2 
diabetes, obesity, and cardiovascular disease in later life; 
ʲ
Search strategy and selection criteria
We searched PubMed [A: between which dates? Month and 
year] with the terms “nephron number”, “nephron 
endowment”, “nephron mass”, “nephrogenesis”, “birth 
weight”, “low birth weight”, “high birth weight”, 
“prematurity”, “preterm birth”, “developmental 
programming”, “developmental origins of adult health and 
disease”, “catch-up growth”, “growth restriction”, “SGA”, and 
“IUGR”, with other keywords including “kidney”, “kidney 
mass”, “kidney size”, “kidney volume”, “diabetes”, “gestational 
diabetes”, “cardiovascular disease”, “obesity”, “human”, 
“hypertension”, “hypertensive disorders in pregnancy”, 
“preeclampsia”, “vitamin A deficiency”, “maternal diet”, and 
“maternal nutrition”. We also looked at the reference lists of 
existing manuscripts, textbooks, and websites. Furthermore, 
we identified data, references, and links by searching the 
WHO, UNICEF, and Google Scholar websites [A: between 
which dates?] with the keywords “low birth weight”, 
“preeclampsia”, “gestational diabetes”, “maternal and 
newborn health”, “nutrition”, and “childhood obesity”. [A: 
did you impose any language restrictions?] We largely 
Ƞ
considered older seminal papers. Some references to 
experimental data were included when these were judged 
necessary to explain ideas strongly supporting the 
pathophysiology but not yet proven in man. 
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development, and unhealthy childhood growth that all 
augment the risk of adult disease.5,6 
Here, we describe how fetal and child health affect 
kidney development and risk of disease. We focus 
mainly on human studies but use experimental data 
when necessary to provide further insight. 
Effect of fetal development on the kidney
About 25 years ago, Brenner and colleagues7 proposed 
that a congenital (developmentally programmed) 
decrease in nephron number could account for why 
some individuals are more susceptible to hypertension 
and renal injury than others. A kidney with fewer 
nephrons was postulated to have a diminished filtration 
surface area, resulting in limitation of sodium excretion 
leading to raised blood pressure and reduction of renal 
adaptive capacity in the setting of injury. This hypothesis 
provided a plausible link between a high prevalence of 
hypertension and renal disease in populations with an 
increased frequency of low birthweight, whereby low 
birthweight was expected to be associated with a lower 
number of nephrons (figure 1).8 Consistent with this 
hypothesis, data from various experimental models 
confirm the association of low birthweight with later-life 
hypertension, mediated, in part, by acquisition of fewer 
nephrons in utero (the pathophysiological mechanisms 
affecting nephrogenesis are reviewed elsewhere).9 
Similarly, in human beings, low birthweight is a risk 
factor for hypertension and chronic kidney disease.10 
[A: please note that we prefer to avoid use of 
abbreviations, for clarity] Low birthweight is a marker of 
poor fetal growth. Risk factors for low birthweight vary 
in developed and developing countries but the global 
incidence is 15% a year [A: correct?], suggesting that 
many children are at risk of hypertension and kidney 
disease in later life (figure 2).11–15 [A: note that refs 11–15 
are mentioned in the figure legend, I’ve renumbered] 
In view of the complexity and far-reaching effect of 
developmental programming, understanding the most 
proximal origins of hypertension and renal disease risk 
is crucial for expansion of public health strategies to 
reduce their global effect.4 
Low birthweight is defined universally as a birthweight 
less than 2·5 kg, and high birthweight is classed as 
a birthweight heavier than 4·0 or 4·5 kg.16 [A: do you 
mean 4·0–4·5 kg? Why the two weights?] Other terms 
used to indicate neonatal size include intrauterine 
growth restriction (IUGR), small for gestational age, and 
large for gestational age. For simplicity, we define low 
birthweight as all babies with a birthweight less than 
2·5 kg, including those who are small for gestational 
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Figure 1: Factors affecting developmental programming of hypertension and kidney disease
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Figure 2: Worldwide prevalence of factors affecting programming of renal disease, by UN region 
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age, and high birthweight as children with a birthweight 
greater than 4·0–4·5 kg, including those who are large 
for gestational age. A premature infant—ie, who is 
born before 37 weeks of gestation—is generally low 
birthweight, which might be an appropriate weight for 
gestational age if growth occurred normally until birth, 
but could be small for gestational age if growth were 
restricted.16
Nephron number in children and adults
The total number of nephrons in the normal adult 
human kidney varies widely.17 The average number of 
nephrons per kidney was assumed to be between 900 000 
and 1 000 000, [A: who made this assumption?] yet the 
observed range is more than tenfold [A: OK?].17 In the 
largest study to date,18 total nephron number ranged 
from 210 332 to 2 702 079 in 176 adults of African-
American ethnic origin and from 227 327 to 1 660 232 in 
132 white individuals.
Birthweight correlates linearly with nephron number 
in adults and children, and nephron number increases 
by 257 426 per kg increase in birthweight,19 suggesting 
(by extrapolation) that nephron numbers are lower 
in people with a low birthweight. Although nephron 
numbers have been measured rarely in adults of known 
low birthweight, nephron numbers were reduced 
significantly in infants with low birthweight.20,21 The total 
number of nephrons in an adult human kidney reflects 
the number of nephrons formed during development 
(nephron endowment) minus the number of nephrons 
subsequently lost; therefore, cumulative injury over time 
could contribute to a kidney reaching a very low nephron 
number, leading to disease.17 Human nephrogenesis 
ends at around 36 weeks of gestation, after which 
no new nephrons can form.20 In an Australian study, 
nephron number in 15 infants who died before the age 
of 3 months ranged 4·5-fold, from 246 181 to 1 106 062, 
suggesting that much of the variation in nephron 
number in adults is established before birth.22
Developmental determinants of low 
nephron number
The most robust clinical surrogates for low nephron 
number are low birthweight and prematurity. However, 
not all factors that affect nephron number result in low 
birthweight, therefore, awareness of risk factors for low 
nephron number per se is also important (table 1). [A: 
note that ref 23 is mentioned in the figure legend, I’ve 
renumbered] The most important risk factors, some of 
which could be modifiable with public health 
interventions, include maternal health and nutrition, 
prenatal and postnatal environments, prematurity, and 
genetic predisposition.24
Maternal factors
Figure 1 shows maternal health factors that could affect 
the risk of low birthweight and prematurity and should 
be judged risk factors for low nephron number in 
offspring.25 Mothers who themselves were low 
birthweight, compared with mothers who were not, were 
more likely to have babies of low birthweight (odds 
ratio 1·8, 95% CI 1·3–2·5), a finding that is independent 
of socioeconomic factors, suggesting a genetic or 
epigenetic intergenerational effect.26 
Hypertensive disorders during pregnancy 
Disorders linked to high blood pressure in pregnancy 
were noted in 8·4 million women worldwide in 2004, 
and these are major risk factors for low birthweight.27 As 
outlined elsewhere in this series, [A: please provide the 
reference so we can cross-link papers] risk of pre-
eclampsia in a mother is increased if she herself was 
low birthweight (odds ratio 1·69, 95% CI 1·4–2·02), 
premature (1·95, 1·54–2·47), or either of the mother’s 
parents [A: correct?] were born after pre-eclamptic 
pregnancies (2·2, 2·0–2·4), showing the complexity of 
intergenerational programming.28–30 Pre-pregnancy 
maternal chronic kidney disease and hypertension are 
also relevant risk factors for pre-eclampsia, low 
birthweight, and preterm delivery.31 In a Cuban cohort,21 
maternal hypertension was associated with low 
birthweight, which in turn was associated with low 
nephron number. 
Effect on kidney
Prenatal
ʬțțț Small infant kidney size
Low birthweight Decreased nephron number
Growth restriction ʬȢǧȠ
Prematurity Decreased nephron number; reduced kidney 
size in growth-restricted children
Genetics
RET ǩȜȟȢȡǪ Ȝțʏ
PAX2 AAA haplotype Ȝțʏ
Combined RETǩȜȟȢȡǪPAX2 AAA 
haplotype
ȝȞʏ
I/D ACE polymorphism ȣʏ
BMPR1AȢȤȝȝȣȟȡ ȜȞʏ
OSR1 rs12329305(T) polymorphism Ȝȝʏ
Combined OSR1 and RET polymorphisms ȝȝʏ
Combined OSR1 and PAX2 polymorphisms ȝȢʏ
ALDH1A2 rs7169289(G) polymorphism ȝȝʏ
Postnatal
Renal failure Decreased nephron number
Growth restriction ʬȢǧȠƾ
ȡǧȟ
Catch-up growth, childhood and adolescent overweight or 
obesity
Increased glomerular volume; faster 
progression of renal disease
ȝȞƽǀ[A: please obtain permission to 
adapt this table from the publisher] RET=tyrosine kinase receptor. PAX2=paired box gene 2. ACE=angiotensin-
converting enzyme. OSR=Odd-Skipped related. BMPR=bone morphogenic protein receptor. ALDH=aldehyde 
dehydrogenase. See appendix for relevant references.
Table 1: Developmental factors associated with nephron number, kidney size, and function
See Online for appendix
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Gestational diabetes
The worldwide prevalence of gestational diabetes is 
poorly recorded, but is reported as 0·1–25·3%.32 Maternal 
obesity, now present in 15–20% of pregnancies, is a 
strong risk factor for gestational diabetes, as is maternal 
prematurity.30,33 In experimental models, maternal hyper-
glycaemia is associated with reduced nephron number, 
raised blood pressure, microalbuminuria, and 
diminished glomerular filtration rate in offspring.34 In 
adult children whose mother had diabetes, compared 
with those who had a diabetic father, renal functional 
reserve was decreased, suggesting a reduction in 
nephron number was acquired during exposure to 
gestational diabetes.35 Maternal diabetes is also associated 
with a threefold increased risk of renal agenesis and 
dysgenesis; therefore, hyperglycaemia strongly affects 
fetal renal development.36 Furthermore, gestational 
diabetes is sometimes associated with high birthweight 
in infants, which is a known risk factor for subsequent 
hypertension, type 2 diabetes, renal disease, and 
cardiovascular disease, although the effect on nephron 
number is unknown.37
Maternal behaviour
Smoking by the mother has been associated with low 
birthweight and low nephron number.21 Alcohol 
consumption is linked to a dose-dependent increased 
risk of prematurity and fetal growth restriction.38 In 
experimental models, gestational alcohol exposure 
impaired embryonic ureteric bud branching, result ing 
in low nephron number, and could be a risk in 
human beings.39
Prenatal factors
Maternal diets deficient in protein, total calories, or iron 
all reduce nephron numbers in experimental models and 
are most usually associated with low birthweight [A: are 
the diets most usually associated with LBW?].9 In human 
beings, maternal protein and micronutrient deficiencies 
are common in developing countries, and maternal 
malnutrition, underweight, iron deficiency, and anaemia 
are all recognised risk factors for low birthweight.40 
Vitamin A deficiency is also highly prevalent among 
pregnant women worldwide (figure 2).12 In animals, 
maternal diets deficient in vitamin A, resulting in 
amounts similar to those seen in deficient people, induce 
a dose-dependent reduction in nephron number, whereas 
vitamin A supplementation augments nephron number.41 
Importantly, vitamin A deficiency alone does not cause 
low birthweight, suggesting the effect of deficiency could 
be overlooked if normal birthweight were presumed to 
exclude an adverse developmental environment. The 
active metabolite of vitamin A—retinoic acid—regulates 
tran scription of RET, a tyrosine kinase receptor important 
for kidney development. Plausibly, therefore, vitamin A 
intake could be a vital determinant of nephron number. 
Indeed, maternal vitamin A deficiency was associated 
with significantly smaller newborn adjusted renal 
volume in Indian babies compared with Canadian 
infants, probably reflecting lower nephron numbers 
(table 1).42 [A: how relevant is the Indian vs Canadian 
comparison? Please clarify, or remove] 
Prematurity 
About 9·6% of liveborn babies are premature (figure 2), 
and prematurity is associated with raised blood pressure, 
renal disease, and cardiovascular disease in later life.13,16 
Nephron number correlates with gestational age; in 
premature infants, nephrogenesis  might continue for 
a period after birth, although glomeruli are large and 
abnormal and renal maturation seems accelerated.20,43 
Consistent with these morphological abnormalities, 
prematurity is a risk factor for acute kidney injury, which 
is an independent predictor of mortality and subsequent 
chronic kidney disease in very low birthweight infants.16 
Postnatal factors
Human nephrogenesis is complete at term; however, 
ongoing nephrogenesis has been recorded up to 40 days 
after birth in infants born before 30 weeks of gestation.43 
Thus, a window of vulnerability exists in preterm infants, 
during which time kidney development can be affected 
(table 1). Indeed, extrauterine growth restriction was 
associated with a significantly lower glomerular filtration 
rate in very low birthweight children at a mean age of 
7·6 years; conversely, the frequency of renal impairment 
was 33% lower at 6·4 years among very low birthweight 
children who had gained more weight in neonatal 
intensive care, showing the importance of early nutrition 
on kidney development.44,45 Nephron number was low in 
premature infants who developed renal failure before 
death, although whether renal failure [A: correct? We say 
what is meant by ‘this’] was a cause or outcome of low 
nephron number is unknown.43 
Many premature infants receive perinatal drugs 
such as non-steroidal anti-inflammatory agents, gluco-
corticoids, and aminoglycosides. Extrapolating from 
experimental models, these and other drugs can affect 
nephron number and increase the risk of acute kidney 
injury in infants.46 However, follow-up of people whose 
mother was exposed to betamethasone for 48 h before 
birth did not show any increase in blood pressure 
at age 30 years compared with those whose mother 
had received a placebo.47 Short-term steroids might, 
therefore, not affect kidney development, but the effects 
of such common drugs on human nephrogenesis merit 
further study.
Genetics
Rare genetic and congenital abnormalities resulting in 
renal hypoplasia contribute to about half of all cases of 
childhood end-stage renal disease.48 Common poly-
morphisms in several genes known to participate in 
kidney development correlate with altered gene tran-
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scription and newborn kidney size, which is proportional 
to nephron number (table 1).22 These studies have been 
undertaken mainly in white populations [A: we avoid 
‘Caucasian’ unless you do mean ‘from the Caucasus’. Is 
white OK or do you mean white European?], therefore 
implications for other populations need to be 
investigated.22,49,50 The molecular mechanisms regulating 
nephrogenesis are reviewed elsewhere.51 Individual 
permutations of these genetic variants could account for 
the wide variability seen in human nephron numbers, 
because some mutations reduce and some augment 
kidney volume. Interactions between genetic poly-
morphisms and environmental circumstances during 
kidney development have not been studied. Gene 
microarray analysis of neonatal kidneys has shown global 
downregulation of gene expression in experimental 
models of maternal low protein diet or placental 
insufficiency.52 Therefore, altered levels of gene expression 
resulting from a polymorphism could become even more 
amplified under conditions of superimposed maternal 
nutrient deficiency, further decreasing nephron number.53
Clinical surrogates for nephron number
At present, all reports of human nephron number have 
come from kidneys obtained at autopsy. In view of the 
current reliance on autopsy specimens, surrogate 
markers for nephron number are important (table 2).
Similar to total nephron number, mean glomerular 
volume varied up to tenfold in an Australian series of 
420 kidneys from people in five ethnic groups.54 Total 
nephron number differs inversely with mean glomerular 
volume.17 An increase in glomerular volume probably 
reflects compensatory hypertrophy and hyperfiltration 
in individual nephrons. Indeed, total filtration surface 
area is fairly well preserved in kidneys with low nephron 
number, possibly at the expense of increased glomerular 
pressure, which can accelerate further nephron loss.18 
Moreover, increased glomerular size is a predictor of 
poorer renal outcomes in African-American populations, 
Native Americans (Pima Indians), and Indigenous 
Australians, and without other causes, should be judged 
a surrogate for low nephron number.9 In view of the 
heterogeneity and hypertrophy occurring in glomeruli, 
kidney size does not correlate consistently with nephron 
number in adults, but the relation seems linear in 
infants younger than 3 months.22,55
Birthweight, prematurity, and blood pressure
Studies of monozygotic twins, in which the twin who 
weighed the least subsequently had higher blood 
pressure, suggest that environmental programming 
could be more crucial than genetic factors.56 Low 
birthweight and prematurity have been associated 
consistently with increased risk of higher blood pressure 
in later life (panel).57,58 In a meta-analysis of 27 studies,58 a 
2·28 mm Hg (95% CI 1·24–3·33) increase in systolic 
blood pressure was recorded in individuals whose 
Association with nephron number
Clinical surrogate
Low birthweight ȝȠȢȟȝȡƽ
Prematurity Decrease in glomerular number, proportional to gestational age, in premature 
compared with term infants
Sex Ȝȝʏ
Age ȞȡȢȡȜȣǩǪ
Adult height ȝȣțțț
Kidney mass ȝȞȟȠȤǩǪ
Glomerular volume Inverse correlation between glomerular volume and nephron number
Ethnic origin Reduced number in Indigenous Australians compared with white and black US 
population
Possible correlates
Gestational diabetes 
exposure
ʲ
fathers
ȝȞƽǀ [A: please obtain permission to 
adapt this table from the publisher] See appendix for relevant references. 
Table 2: Clinical surrogates for nephron number
Panel: Clinical associations with programming of 
kidney function
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ ʬ
Ǧ 
Ǧ 
Ǧ 
Ǧ ǂ
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ ʬ
Ǧ 
Ǧ 
Ǧ 
Ǧ ǂ
Ǧ ǂ
and adolescence, particularly after low birthweight
Ǧ 	
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
Ǧ 
ȝȞƽǀ[A: 
please obtain permission to adapt this table from the publisher] 
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birthweight was less than 2·5 kg, compared with those 
heavier than 2·5 kg. Unfortunately, in most studies to 
date, a distinction has not been made between low 
birthweight as a result of growth restriction at any 
gestational age and prematurity with appropriate size for 
gestational age. Therefore, the potential for unmeasured 
confounding or effect modification by gestational age, 
growth restriction, or both must be borne in mind.16
Findings of a systematic review of ten studies showed 
that, in preterm babies born at a mean gestational age of 
30·2 weeks and with a mean birthweight of 1·28 kg, blood 
pressures in later life were 2·5 mm Hg higher (95% CI 
1·7–3·3) than in infants born at term.57 Prematurity has 
been associated predominantly with high, but still normal, 
blood pressures, because cohorts studied are still fairly 
young. Overt hypertension has been recorded in two 
studies of premature babies: in the first, the children 
were age 2 years and the prevalence of hypertension 
(defined as systolic or diastolic blood pressure greater 
than the 95th percentile) was 30% overall; and in the 
second, pregnant women were age 25 years and chronic 
hypertension was present in 1·4% of those born preterm 
compared with 0·8% born at term (odds ratio 1·7, 95% CI 
1·32–2·20).30,59 Researchers have tried to dissect the relative 
roles of prematurity and growth restriction; some suggest 
prematurity alone is the predominant risk factor, whereas 
others judge small for gestational age to be most important 
when ascertaining risk of raised blood pressure and kidney 
disease.60 These differences show the complex interplay of 
intrauterine and extrauterine events and timing of insults, 
which vary considerably in premature infants.16 
Because odd ratios for risk of high blood pressure were 
similar between the meta-analysis of low birthweight58 
and the systematic review of prematurity,57 and since 
prematurity does not account for all babies with low 
birthweight, both low birthweight and prematurity 
must be deemed important risk factors for high blood 
pressure. The association starts in early childhood 
and becomes augmented in adulthood, at which stage 
blood pressures typically reach hypertensive ranges, 
suggesting the programming effects are compounded by 
growth, age, and lifestyle. 
Nephron number and blood pressure
In rodents, nephrogenesis continues for up to 7–10 days 
after birth, providing a window—similar to that seen in 
premature infants—during which postnatal events can 
affect nephron number. In rats of low birthweight, rescue 
of nephron number by optimisation of postnatal 
nutrition abrogated development of subsequent hyper-
tension; conversely, undernutrition after birth of rat pups 
of normal birthweight led to lower nephron numbers 
and higher blood pressure.61,62 These data accord with a 
role of nephron number in hypertension. 
In a German cohort of adults who died in accidents, 
nephron numbers were significantly lower among 
those with hypertension compared with normotensive 
controls.63 Low nephron numbers have also been 
associated with raised blood pressure in Indigenous 
Australians and white populations from the USA and 
Australia, although birthweights were unknown.64 
The relation between nephron number and blood 
pressure in people of African origin seems less clear, 
but glomerular volume is a significant independent 
predictor of high blood pressure in this population.64 
Additional factors probably contribute to hypertension 
in African populations, but the effect of birthweight 
or the contribution of nephron number to severity of 
hypertension, for example, cannot be excluded.
Observations in patients [A: ref?] of normalisation of 
glomerular filtration surface area despite low nephron 
numbers argue against the hypothesis that sodium 
excretion is restricted. However, in patients and in 
experimental models, low birthweight and low nephron 
number were associated with a salt-induced increase in 
blood pressure (panel).65,66 Salt sensitivity in young adults 
and children correlates inversely with birthweight, 
independent of glomerular filtration rate, suggesting a 
primary defect in renal sodium handling.67,68
Evidence that hypertension is not eliminated despite 
normalisation of nephron number in some experimental 
models suggests that additional factors participate 
in developmental programming of hypertension.69 
Experimental work has shown alterations in renal tubule 
sodium transporter expression and systemic changes in 
vascular function, neuroendocrine adaptations to stress, 
insulin sensitivity, and sympathetic nervous system 
activity.69 Nephron number, therefore, is not the sole 
programmed risk factor for hypertension, but it is likely 
to exacerbate any risk and contribute to kidney disease.
Renal function, birthweight, and nephron mass
Glomerular filtration rate
Without compensatory hyperfiltration, a kidney with a 
reduced number of nephrons should have a diminished 
glomerular filtration rate. Indeed, glomerular filtration 
rate extrapolated from amikacin clearance on day 1 of life, 
preceding any compensatory adaptation, was decreased 
significantly in premature and low-birthweight infants 
compared with term controls.70 Glomerular filtration rate 
measured by inulin clearance was significantly lower at 
age 7·6 years in children who had been born premature 
and had severe growth restriction compared with non-
growth-restricted controls.44 In this study, the effects were 
similar in children who were growth-restricted prenatally 
or postnatally in intensive care, again showing the 
importance of early nutrition. In a meta-analysis of eight 
studies,10 the odds ratio for reduced glomerular filtration 
rate with low birthweight was 1·79 (95% CI 1·31–2·45). 
Proteinuria
Microalbuminuria is one of the earliest signs of 
glomerular hyperfiltration, and transition to macro-
albuminuria accords with ongoing renal injury. Hoy and 
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colleagues71 reported an odds ratio of 2·8 (95% CI 1·26–
6·31) for macroalbuminuria in Indigenous Australians 
who were low birthweight compared with those of 
normal birthweight. In this population, albuminuria was 
associated with a significant increase in cardiovascular 
and renal deaths, emphasising its clinical relevance.72 
Many study findings have since confirmed this 
association, reflected in an odds ratio of 1·81 (95% CI 
1·19–2·77) for albuminuria in low-birthweight 
individuals in a meta analysis of nine studies.10 In Native 
Americans (Pima Indians), however, the relation is 
U-shaped, with an increased risk of proteinuria with in 
those whose birthweight was less than 2·5 kg and greater 
than 4·5 kg.37 This population has a high prevalence of 
gestational diabetes, exposure to which was the strongest 
predictor of proteinuria in the high-birthweight people.37
Chronic kidney disease and end-stage renal disease
Amplified progression of primary renal diseases has 
been noted in people with low birthweight. [A: which 
reference? Ref 9?] In individuals with diabetes, 
prevalence of nephropathy has been associated with 
both low and high birthweight, and short stature.37,73 All 
these observations suggest that abnormal fetal growth 
increases long-term risk of renal disease (panel). 
Consistent with this hypothesis, the odds ratio for 
chronic kidney disease (including end-stage renal 
disease) associated with low birthweight was 1·73 (95% 
CI 1·44–2·08) from 18 studies.10 In population-based 
studies, a U-shaped relation has been reported between 
birthweight and risk of chronic kidney disease or end-
stage renal disease, suggesting high birthweight is also 
important.8,74,75 In some studies, the programmed risk of 
chronic kidney disease seems to be greater in men.74 
However, the differential effect of sex on renal 
programming is quite variable and needs further 
study.75,76 
Similar to programming of blood pressure risk, 
nephron number is unlikely to be the sole factor 
contributing to risk of renal disease, and a low nephron 
number will probably not be sufficient to cause 
renal disease without additional variables. Moreover, 
developmental programming of related disorders—
eg, type 2 diabetes, cardiovascular disease, insulin 
resistance and obesity—could increase renal risk 
further.4,16 Programming of these disorders might take 
place simultaneously in a developing fetus, depending 
on timing and nature of the insults. All infants subjected 
to adverse intrauterine conditions should be judged at 
risk for all these disorders. 
Effect of childhood weight gain on kidney 
disease and function
Postnatal malnutrition and clinical circumstances can 
affect nephrogenesis, childhood renal function, and long-
term risk of renal disease (figure 1).16,43,45 In rats with low 
birthweight, low nephron numbers were restored to 
normal and development of hypertension was abrogated 
by provision of adequate postnatal nutrition.61 When low-
birthweight rats were overfed after birth, nephron 
numbers remained low and the rodents developed obesity, 
hypertension, and renal injury over time.77 In rats with 
normal birthweight that were overfed postnatally, despite 
a higher-than-normal nephron number, blood pressure, 
proteinuria, and glomerulosclerosis were all increased in 
adulthood.78 Taken together, these data suggest that 
normalisation of postnatal nutrition can be beneficial, but 
overfeeding is probably deleterious. In infants, postnatal 
weight gain and nutrition have been implicated in 
developmental programming of adult disease.79
Catch-up growth in children who were of low 
birthweight has long been advocated, particularly 
in developing countries, to boost resilience against 
infections and reduce risk of undernutrition, stunting, 
and cognitive impairment.5 However, in many 
populations worldwide, accelerated weight gain or an 
increase in body-mass index, even in children with a 
normal birthweight, has been associated consistently 
with amplified risk of adult hypertension, type 2 
diabetes, and cardiovascular disease.79–81 This effect 
grows as the child ages: upward crossing of weight 
or body-mass index percentiles in mid-childhood or 
adolescence is associated with strong adverse effects on 
later risk, whereas upward crossing in infancy (younger 
than 1 year) has no or little effect on later blood pressure 
and could protect against diabetes.81–83 The gain in 
childhood body-mass index associated with increased 
risk of adult disease is not always excessive in terms 
of absolute number. In many developing countries, 
children who grow rapidly can still be small by 
international weight standards, but upwards crossing of 
body-mass index percentiles seems to be the important 
factor.81–83 Therefore, one cross-sectional measurement of 
a child’s weight or body-mass index could be misleading 
in such circumstances, emphasising the need for growth 
tracking in early childhood.
Children born with a low birthweight who have an 
adequate nutrient supply tend to gain weight rapidly.5 
Among 22-year-old British adults, systolic blood 
pressure increased by 1·3 mm Hg (95% CI 0·3–2·3) for 
every SD decrease in birthweight and rose by 1·6 mm 
Hg (0·6–2·7) for every SD gain in childhood weight 
between age 1 year and 10 years.84 An association is well 
recognised between rapid childhood weight gain and 
raised blood pressure and increased arterial stiffness, 
which is sometimes already evident in childhood.82 
In a study of 216 771 Scandinavian adults,80 those 
with a birthweight of 2·5 kg and a body-mass index 
of 17·7 kg/m2 (overweight) at age 7 years had a 44% 
increased risk of cardiovascular disease in adulthood 
compared with those with a median birthweight of 
3·4 kg and a body-mass index of 15·3 kg/m² at age 
7 years. [A: is this BMI “normal”?] The highest risk 
of raised blood pressure and cardiovascular disease, 
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therefore, was present in children born with low 
birthweight who became heavy.80 Importantly, body-
mass index was associated strongly and positively with 
cardiovascular disease risk in this study, independent 
of birthweight, showing the importance of childhood 
obesity itself as a risk factor for adult disease. 
The prevalence of childhood obesity is increasing 
worldwide (figure 2).14 Risk factors for obesity include 
high birthweight, exposure to gestational diabetes, and 
early postnatal weight gain.85 These factors are also 
associated independently with altered nephrogenesis 
and increased risk of hypertension, type 2 diabetes, 
and renal dysfunction (figure 1). Furthermore, obesity 
per se is a risk factor for progression of renal disease; 
therefore, superimposition of the burden of obesity on a 
small kidney with fewer nephrons is likely to compound 
the risk and act as a second hit, accelerating renal 
disease progression.86 How can we optimise postnatal 
growth and positively change any subsequent disease 
risk, particularly in low-birthweight infants? Avoidance 
of obesity seems to be a safe guiding principle.
Early growth and kidney function 
The association of rapid childhood weight gain with high 
blood pressure, diabetes, and obesity is likely to compound 
any primary programmed renal risk. Indeed, in a 
retrospective analysis of 80 children with proteinuric 
kidney disease, renal disease progressed fastest in those 
who had been premature and became obese.87 Glomerular 
size was increased in all obese children, whether premature 
or term, whereas kidney size remained small in all those 
who had been premature, independent of obesity. 
Similarly, among infants with very low birthweight who 
developed neonatal acute kidney injury, excessive weight 
gain was a predictor of poorer renal function at a mean age 
of 7·5 (SD 4·6) years.88 The effect of infant weight gain on 
long-term renal function remains unknown. 
Mechanisms linking kidney disease and 
weight gain
[A: new heading OK?] Several mechanisms have been 
proposed to explain the amplification of renal and 
cardiovascular disease risk by rapid weight gain after 
growth restriction. One possibility is development of 
premature senescence.89 Cellular senescence is a state of 
growth arrest induced by upregulation of the cell-cycle 
inhibitors P53, P21, and P16INK4a.90 Upregulation of the 
genes for these proteins can be induced by progressive 
telomere shortening, which takes place with cell 
replication and is a robust marker of ageing, and by 
reactive oxygen species induced by cellular stress.90 
Chronic cardiovascular and renal diseases are 
associated with increased expression of senescence 
markers.91 In experimental models, low birthweight 
followed by rapid postnatal weight gain was associated 
with shorter telomeres and amplified expression of 
senescence markers in the kidneys, heart, and aorta, 
in addition to premature death, which all accord with 
accelerated ageing.89,92,93 Low birthweight was also 
associated with higher renal and cardiovascular mortality 
in an Indigenous Australian cohort, which accords with 
these experimental findings.94 
Premature senescence in the kidney might be 
attributable to ongoing hyperfiltration injury in kidneys 
with a few nephrons, compounded by a rapid increase 
in body size. Leukocyte telomere length did not differ 
between British babies of low and normal birthweight,95 
but among 5-year-old children from Bangladesh, 
telomeres were significantly shorter in those who were 
of low birthweight.96 
Senescence is linked to oxidative stress. In children 
born small for gestational age, compared with controls 
[A: how were controls matched? Appropriate size for 
gestational age?], markers of oxidative stress were 
highest in those who experienced catch-up growth.97 
The link between nephron numbers, catch-up 
growth, premature senescence, and development of 
hypertension and renal disease seems plausible, but it 
has not yet been confirmed. 
Conclusion 
The association between fetal and childhood development 
and increased risk of adult disease is now quite convincing.3 
Low birthweight and prematurity are associated with 
raised blood pressure and decreased renal function, 
manifesting in early childhood, which could progress to 
overt disease in adulthood. Nutrition is a cornerstone of 
this association. Maternal nutrition and health before and 
during pregnancy are crucial for fetal growth and for 
development of a kidney with enough nephrons to 
maintain homeostasis in response to dietary and metabolic 
stresses and to sustain function in the face of superimposed 
nephron loss. Early postnatal nutrition, particularly after 
premature birth, is also important for renal development. 
Furthermore, upward crossing of weight or body-mass 
index percentiles after the infant period programmes risk 
of hypertension and renal disease. Developmental 
programming has an intergenerational effect, because low 
birthweight increases the risk of maternal pre-eclampsia, 
obesity, and gestational diabetes, which all in turn further 
compound future risks in their offspring. 
Growing knowledge and understanding of the patho-
physiology of developmental programming has identified 
at-risk populations that could be targets for screening 
and interventions to interrupt this cycle. Identification of 
nutritional deficiencies within populations (eg, vitamin A 
deficiency) ought to prompt public health interventions 
to correct these deficiencies well before pregnancy. 
Adequate antenatal care should identify women who 
develop pre-eclampsia and gestational diabetes, optimise 
their care during pregnancy, but lead to lifestyle education 
and lifelong screening of these women for later disease. 
Currently, a few women worldwide are screened for 
gestational diabetes.32 With the rising prevalence of 
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obesity, such screening should be more widespread. 
Similarly, according to the UNICEF project Childinfo, 
only about 60% of all children are weighed at birth, and 
this number should increase. Several interventions to 
reduce maternal and childhood malnutrition, where 
prevalent, have been effective: supplementation of protein 
energy intake during pregnancy has reduced the risk of 
term low-birthweight babies by 32%; supplementation 
of multiple micronutrients in pregnancy decreased the 
proportion of children with low birthweight by 16%; 
and implementation of malaria prophylaxis diminished 
the risk of low-birthweight babies by 37%.98 Vitamin A 
supplementation did not affect birthweight but did lower 
neonatal mortality (relative risk 0·8, 95% CI 0·66–0·96), 
whereas the relative risk of pre-eclampsia was 0·45 (0·31–
0·65) with maternal calcium supplementation.98,99 As far 
as we know, no study has followed up the offspring of 
such supplemented pregnancies to ascertain whether risk 
of adult disease has been altered, but we should assume a 
positive effect. 
In later life, regular cardiovascular exercise abrogates 
the metabolic outcomes of being small at birth among 
men.100 Identification of at-risk pregnancies and 
offspring of both high and low birthweight should 
prompt maternal education to optimise childhood 
nutrition and activity to prevent obesity. Prematurity 
and low birthweight are among the top ten contributors 
to the global burden of disease, calculations that 
might not always have included the long-term costs 
of programmed adult non-communicable diseases.1,27 
Acknowledgment of the role of developmental 
programming in hypertension and renal disease 
risk, and implementation of locally adapted pre-
emptive strategies in individual countries, will have 
important long-term benefits in terms of future health, 
productivity, and cost savings worldwide.
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